This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Elahere (mirvetuximab soravtansine-gynx)
General Description:
Elahere (mirvetuximab soravtansine-gynx) is an antibody-drug conjugate (ADC) and microtubule inhibitor used for the treatment of FR-alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. It selectively targets cancer cells expressing folate receptor alpha (FR-α), delivering a cytotoxic agent to slow tumor growth and improve patient outcomes.
Elahere is administered intravenously under the supervision of a qualified oncologist, with dosage and treatment schedules tailored to the patient’s condition and response.
Getting Elahere (mirvetuximab soravtansine-gynx) in India
Elahere was approved by the FDA in November 2022. While it may not yet be commercially available in India, patients can access it legally through a Named Patient Program (NPP) with guidance from a licensed physician.
MitoGENE supports Indian patients in obtaining Elahere safely, coordinating all regulatory approvals, import permits, and logistics to ensure a secure and compliant process.
Disease Indication:
• Gynaecological Cancer / FR-alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
Manufacturer:
AbbVie Ltd
Usage:
Intravenous
Medicine Approved By:
• Food and Drug Administration (FDA)
Available Dosage Form & Package:
• Single-dose vial: 100 mg/20 mL (5 mg/mL)
Shipping:
Cold Chain Shipping
Elahere requires cold chain shipping to protect it from heat, light, and handling. Specialized medical couriers use temperature-controlled packaging and vehicles to maintain stability and effectiveness, ensuring the medicine remains safe for patient use.
How to Access Elahere (mirvetuximab soravtansine-gynx) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Elahere (mirvetuximab soravtansine-gynx) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
